BiotechTube
Home/IO Biotech/Daniel G. Mannix
DG

Daniel G. Mannix

Senior Vice President, Regulatory Affairs

IO Biotech

Therapeutic Areas

OncologyImmunology

IO Biotech Pipeline

DrugIndicationPhase
IO102-IO103 (Cylembio®) + pembrolizumabFirst-line Advanced MelanomaPhase 3
IO102-IO103 + pembrolizumabAdjuvant Treatment of MelanomaPhase 2
IO102-IO103 + nivolumabAdvanced Solid Tumors (e.g., NSCLC, Bladder Cancer)Phase 1/2

Leadership Team at IO Biotech

MZ
Mai-Britt Zocca
Founder, President and Chief Executive Officer
QA
Qasim Ahmad
Chief Medical Officer
AS
Amy Sullivan
Chief Financial Officer
DS
Devin Smith
General Counsel
EF
Eric Faulkner
Chief Technical Officer
FM
Faiçal Miyara
Chief Business Officer
MH
Mads Hald Andersen
Co-Founder, Scientific Advisor
IM
Inge Marie Svane
Co-Founder, Clinical Advisor
MS
Marjan Shamsaei
Senior Vice President Commercial and Portfolio Lead
DV
David V. Smith
Member of the Board of Directors
View full IO Biotech profile